Skip to main content
OpenTrials
Completed

NCT Number: NCT03794505

Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis

Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Shoulder Arthritis

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Department of Orthopedics, UMAE "Dr. Victorio de la Fuente Narváez" IMSS-UNAM. Ciudad de México, México

Mexico City, Gustavo A Madero, 07760, Mexico

About this study

To describe the efficacy in pain management and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in patients with glenohumeral arthritis

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • IMSS affiliated
  • Glenohumeral arthritis diagnosed

Exclusion criteria

  • Previusly treatment for the same disease
  • No follow up
  • Dead

Treatment and study plan

Methylprednisolone Acetate

Drug

depo-medrol 40 mg

Other names: depo-medrol 40 mg

Lidocaine 2% Injectable Solution

Drug

2ml of 2% lidocaine

Other names: xilocaine

Ropivacaine HCl Inj 7.5 MG/ML

Drug

25 mg

Other names: Ropivacaine

Primary outcomes

  1. Pain before

    Time frame: VAS before intervention

    visual analogue scale

  2. Pain 2 months after

    Time frame: VAS 2 months after

    Visual analogue scale 2 months after procedure

  3. Pain 6 months after

    Time frame: VAS 6 months after

    Visual analogue scale 6 months after procedure

Secondary outcomes

  1. Quality of life before procedure

    Time frame: SF12v2 before procedure

    SF12v2 Health related quality of life before procedure

  2. Quality of life 2 months after procedure

    Time frame: SF12v2 2 months after

    SF12v2 Health related quality of life 2 months after

  3. Quality of life 6 months after procedure

    Time frame: SF12v2 6 months after

    SF12v2 Health related quality of life 6 months after

Sponsors and collaborators

Lead sponsor

Instituto Mexicano del Seguro Social

Other Gov

Registry information

Official study title

Health Related Quality of Life and Pain Managment Using Infiltration or Suprascapular Nerve Block Ultrasound Guided in Patients With Glenohumeral Arthirtis

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jan 7, 2019
Registry last updated
Jan 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.